INTS Buzzes on Reddit as Retail Investors Bet on Biotech Breakthrough

INTS ranked No. 2 by discussion score on October 31, with 19 posts, 447 comments, and a strongly bullish sentiment of 0.63.
$INTS FDA approval catalyst years down the line.
r/pennystocksbot-driven hype cycle

The Catalyst: A Novel Drug Delivery Platform

The bulk of the bullish case for

$INTS on Reddit focused on the company's lead drug candidate, INT230-6, and more importantly, its non-covalent drug delivery platform. One user on r/10xPennyStockshuge breakthrough that could allow for local injection of chemotherapy rather than systemic treatment, noting that roughly 90% of cancers are solid tumors. Another user in r/pennystocks argued that a successful phase 3 readout and FDA approval could eventually support a market cap of $1 billion to $5 billion, implying a 20x to 100x upside from the stock's recent price of around $0.80 per share.

Red Flags and Skepticism

Despite the enthusiasm, several prominent voices urged caution. A long post in r/pennystocksbaited by $INTS bots and cautioned against the euphoria often surrounding small-cap pharma stocks. These skeptical posts helped shape a measured tone even as the ticker's overall sentiment remained positive.

Conference Call and Community Engagement

On October 31, the company hosted a conference call that was shared widely on r/10xPennyStocks. The call appears to have served as a key engagement event for retail investors, keeping the ticker top of mind. The combination of a novel medical thesis, a clear upcoming catalyst, and a vocal community helped drive

$INTS to a score rank of 2 across Tendie.bot tracked subreddits, with 985 upvotes and 447 comments across 19 posts.

INTS

The contrast between bullish long-term holders and skeptical short-term traders created a rich debate, but the prevailing sentiment was net bullish. For now, the Reddit crowd appears willing to wait for the next major data readout.

Subscribe to Tendie.bot for more market recaps.